Shinichiro Muraoka

Stock Analyst at Morgan Stanley

(1.39)
# 3,615
Out of 5,023 analysts
35
Total ratings
53.3%
Success rate
-1.5%
Average return

Stocks Rated by Shinichiro Muraoka

Takeda Pharmaceutical Company Limited
Sep 4, 2026
Reiterated: Buy
Price Target: ¥6,300 → ¥7,000
Current: ¥5,643
Upside: +24.05%
Sawai Group Holdings Co., Ltd.
Aug 12, 2026
Downgraded: Hold
Price Target: ¥2,000 → ¥1,800
Current: ¥1,589
Upside: +13.28%
Otsuka Holdings Co., Ltd.
Apr 30, 2026
Reiterated: Buy
Price Target: ¥13,200 → ¥14,100
Current: ¥11,320
Upside: +24.56%
Kyowa Kirin Co., Ltd.
Mar 6, 2026
Downgraded: Sell
Price Target: ¥1,700
Current: ¥2,230
Upside: -23.77%
Daiichi Sankyo Company, Limited
Nov 21, 2025
Reiterated: Buy
Price Target: ¥4,750 → ¥4,950
Current: ¥2,709
Upside: +82.72%
Sumitomo Pharma Co., Ltd.
Aug 22, 2025
Upgraded: Hold
Price Target: ¥1,350
Current: ¥1,614
Upside: n/a
SanBio Company Limited
Jul 2, 2025
Reiterated: Hold
Price Target: ¥1,400 → ¥2,100
Current: ¥941
Upside: n/a
Astellas Pharma Inc.
May 30, 2025
Reiterated: Hold
Price Target: ¥1,750 → ¥1,500
Current: ¥2,245
Upside: n/a
Shionogi & Co., Ltd.
May 30, 2025
Reiterated: Hold
Price Target: ¥2,750
Current: ¥2,786
Upside: n/a
Eisai Co., Ltd.
May 29, 2025
Reiterated: Hold
Price Target: ¥4,100
Current: ¥4,700
Upside: n/a
Reiterated: Hold
Price Target: ¥3,900 → ¥3,800
Current: ¥3,378
Upside: n/a
Reiterated: Buy
Price Target: ¥7,650 → ¥8,050
Current: ¥6,032
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $17.86
Upside: n/a